Novartis launches MS study with Apple's ResearchKit; the FDA considering limiting risk info in drug ads; J&J loses baby powder lawsuit
She is leading commercial partnerships for the point-of-care company.
CVS Health's decision to remove Lilly's Jardiance for J&J's Invokana has analysts wondering if exclusive pricing contracts could shape the future of the GLP-1 class.
The FDA approves Ironwood's gout drug; GSW names new president; Samsung and Takeda to partner on biologic development
Procter & Gamble has revived the campaign with a new spot tackling the lack of confidence during puberty.
Condé Nast, Time Inc., and Vice Media have all recently launched health content businesses.
WPP was added to Sanofi's creative agency roster and GroupM's Mindshare is the drugmaker's new global media agency of record.
Lawmakers to investigate pricing of MS drugs; Mylan will pay $465 million to resolve EpiPen allegations; the FDA approves Pfizer's new cancer drug
Express Scripts to limit opioid coverage; Novo's diabetes drug lowers glucose levels in trial; startup aims to give doctors access to a patient's total costs
The lobbying group said it's unclear what the agency's goal is with this research and how it promotes public health.